Evaluate the Effectiveness and Safety of the OmniHeart 4.0 Percutaneous Ventricular Assist Device in Providing Hemodynamic Support for Patients Undergoing High-risk Percutaneous Coronary Intervention (PCI). | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluate the Effectiveness and Safety of the OmniHeart 4.0 Percutaneous Ventricular Assist Device in Providing Hemodynamic Support for Patients Undergoing High-risk Percutaneous Coronary Intervention (PCI).	High-risk PCI	Active, not recruiting	Not applicable	2026-06-10		NCT07622446

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beijing Chao Yang Hospital	88
China-Japan Union Hospital, Jilin University	16
Chinese Academy of Medical Sciences, Fuwai Hospital	88
First Affiliated Hospital of Xinjiang Medical University	42
First Affiliated Hospital, Sun Yat-Sen University	113
Henan Provincial Chest Hospital	8
Second Hospital of Jilin University	18
Shanghai Dynaheart Medtech Co., Ltd.	1
The Second Affiliated Hospital of Harbin Medical University	36
The Second Hospital of Hebei Medical University	26
Wuhan Asia Heart Hospital	12
Zibo Central Hospital	16

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Shanghai Dynaheart Medtech Co., Ltd	Shanghai	China	1
The Second Affiliated Hospital of Harbin Medical University	Jilin City	China	1